Procaps Group SA (PROC)
2.76
+0.14
(+5.34%)
USD |
NASDAQ |
May 31, 16:00
2.71
-0.05
(-1.81%)
After-Hours: 20:00
Procaps Group Free Cash Flow: 34.06M for Sept. 30, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2023 | 34.06M |
| June 30, 2023 | -7.321M |
| March 31, 2023 | -21.54M |
| December 31, 2022 | -17.47M |
| September 30, 2022 | -22.34M |
| June 30, 2022 | 6.707M |
| Date | Value |
|---|---|
| March 31, 2022 | 8.532M |
| December 31, 2021 | 12.78M |
| September 30, 2021 | 68.85M |
| June 30, 2021 | 38.77M |
| March 31, 2021 | 43.80M |
| December 31, 2020 | 53.00M |
Free Cash Flow Range, Past 5 Years
-22.34M
Minimum
Sep 2022
68.85M
Maximum
Sep 2021
16.49M
Average
10.66M
Median
Free Cash Flow Benchmarks
| Alvotech | -338.67M |
| Moolec Science SA | -12.79M |
| Perspective Therapeutics Inc | -23.28M |
| Electromed Inc | 4.787M |
| Xtant Medical Holdings Inc | -14.80M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 47.39M |
| Cash from Investing (Quarterly) | -7.469M |
| Cash from Financing (Quarterly) | -29.88M |
| Free Cash Flow Per Share (Quarterly) | 0.3877 |
| Free Cash Flow to Equity (Quarterly) | 38.11M |
| Free Cash Flow to Firm (Quarterly) | 48.07M |
| Free Cash Flow Yield | 12.13% |